Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
8th Annual Symposium on Glial-Neuronal Interactions
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.
Episode 24 with Professor Aksel Siva discussing asymptomatic MS
Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging.
Effect of vitamin D on MS activity by disease-modifying therapy class.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
Associations Between Fatigue and Disability, Functional Mobility, Depression, and Quality of Life in People with Multiple Sclerosis.
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
FOCIS: Advanced Course in Basic & Clinical Immunology
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis.
Multiple sclerosis and risk of attempted and completed suicide - a cohort study.
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
The use of hematopoietic stem cells in autoimmune diseases.
Genzyme’s once-daily, oral AUBAGIO® (teriflunomide) approved in Argentina for the treatment of relapsing multiple sclerosis
Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.
Clarity Extension Study
Development of Guillain-Barré syndrome in a patient with multiple sclerosis during treatment with glatiramer acetate.

Pages